Penumbra (PEN) Financials: Revenue & Earnings
PEN$320.15+1.84 +0.58%
$12.61B
Market Cap
79.23
P/E
67.37
Forward P/E
45
Score
Penumbra (PEN) Financials: Revenue & Earnings
PEN price $320.15 +1.84 +0.58%
- Ticker
- PEN
- Price
- $320.15
- Change
- +1.84 +0.58%
- Market cap ?
- $12.61B
- P/E ?
- 79.23
- Forward P/E ?
- 67.37
- Dividend yield ?
- 0.00%
- Beta ?
- 0.70
- Sector
- Healthcare
- Industry
- Medical - Devices
- Stocklytics score
- 45
- Value
- 15
- Quality
- 69
- Growth
- 52
Stocklytics score rationale: value 15, quality 69, growth 52.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 263317000 | 333764000 | 444938000 | 547405000 | 560412000 | 747590000 | 847133000 | 1058522000 | 1194615000 | 1403665000 |
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT…
Earnings and financials
Penumbra, Inc. (PEN) trades at $320.15, with a market cap of $12.61B and a trailing P/E of 79.23. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 263317000 | 333764000 | 444938000 | 547405000 | 560412000 | 747590000 | 847133000 | 1058522000 | 1194615000 | 1403665000 |
Insights · Dividends · Forecast · Financials · Learn